Opioid receptor-like 1 stimulation in the collecting duct induces aquaresis through vasopressin-independent aquaporin-2 downregulation

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Hadrup, Niels ^a   Petersen, Jørgen S ^b   Praetorius, Jeppe ^c   Meier, Eddi ^b   Græbe, Martin ^a   Brønd, Lone ^a   Staahltoft, Dennis ^a   Nielsen, Søren ^c   Christensen, Sten ^a   Kapusta, Daniel R ^d   Jonassen, Thomas E N ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Zealand Pharma AS   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Congestive heart failure; Nociceptin; Phosphorylated aquaporin 2; ZP120C

Indexed keywords

AQUAPORIN 2; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; GLUCOSE; NOCICEPTIN; NOCICEPTIN DERIVATIVE; OPIOID RECEPTOR LIKE 1 RECEPTOR; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR; ZP 120C;

ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; KIDNEY COLLECTING TUBULE; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; URINARY EXCRETION; VASOPRESSIN BLOOD LEVEL; WATER ABSORPTION;

EID: 2942657670     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00329.2003     Document Type: Article

References (44)

1. Apostol E, Ecelbarger CA, Terris J, Bradford AD, Andrews P, and Knepper MA. Reduced renal medullary water channel expression in puromycin aminonucleoside-induced nephrotic syndrome. J Am Soc Nephrol 8: 15-24, 1997.
2. Burgess WJ, Shalmi M, Petersen JS, Plange-Rhule J, Balment RJ, and Atherton JC. A novel computer-driven, servo-controlled fluid replacement technique and its application to renal function studies in conscious rats. Clin Sci (Colch) 85: 129-137, 1993.
3. Calo G. Nociceptin/orphanin FQ receptor ligands. Peptides 21: 935-947, 2000.
4. 2-receptor antagonist on kidney AQP2 expression and subcellular distribution. Am J Physiol Renal Physiol 275: F285-F297, 1998.
5. 2-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol 278: F29-F42, 2000.
6. DiGiovanni SR, Nielsen S, Christensen EI, and Knepper MA. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rats. Proc Natl Acad Sci USA 91: 8984-8988, 1994.
7. Fernandez-Llama P, Andrews P, Nielsen S, Ecelbarger CA, and Knepper MA. Impaired aquaporin and urea transporter expression in rats with adriamycin-induced nephrotic syndrome. Kidney Int 53: 1244-1253, 1998.
8. Fernandez-Llama P, Turner JS, DiBona G, and Knepper MA. Renal expression of aquaporins in liver cirrhosis induced by chronic common bile duct ligation in rats. J Am Soc Nephrol 10: 1950-1957, 1999.
9. Fushimi K, Sasaki S, and Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem 272: 14800-14804, 1997.
10. Giuliani S, Tramontana M, Lecci A, and Maggi CA. Effect of nociceptin on heart rate and blood pressure in unanesthetized rats. Eur J Pharmacol 333: 177-179, 1997.
11. Hager H, Kwon TH, Vinnikova AK, Masilamani S, Brooks HL, Frøkiær J, Knepper MA, and Nielsen S. Immunocytochemical and immunoelectron microscopic localization of α-, β-, and γ-ENaC in rat kidney. Am J Physiol Renal Physiol 280: F1093-F1106, 2001.
12. Hasler U, Mordasini D, Bens M, Bianchi M, Cluzeaud F, Rousselot M, Vandewalle A, Feraille E, and Martin PY. Long term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem 277: 10379-10386, 2002.
13. Hozawa S, Holtzman EJ, and Ausiello DA. cAMP motifs regulating transcription in the aquaporin 2 gene. Am J Physiol Cell Physiol 270: C1695-C1702, 1996.
14. Jonassen TEN, Christensen S, Kwon TH, Langhoff S, Salling N, and Nielsen S. Renal water handling in rats with decompensated liver cirrhosis. Am J Physiol Renal Physiol 279: F1101-F1109, 2000.
15. Jonassen TEN, Nielsen S, Christensen S, and Petersen JS. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis. Am J Physiol Renal Physiol 275: F216-F225, 1998.
16. Jonassen TEN, Promeneur D, Christensen S, Petersen JS, and Nielsen S. Decreased vasopressin-mediated renal water reabsorption in rats with chronic aldosterone-receptor blockade. Am J Physiol Renal Physiol 278: F246-F256, 2000.
17. Kakiya S, Murase T, Arima H, Yokoi H, Iwasaki Y, Miura Y, and Oiso Y. Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats. Endocrinology 141: 4466-4471, 2000.
18. Kapusta DR. Neurohumoral effects of orphanin FQ/nociceptin: relevance to cardiovascular and renal function. Peptides 21: 1081-1099, 2000.
19. 2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. J Pharmacol Exp Ther 289: 173-180, 1999.
20. Kapusta DR, Sezen SF, Chang JK, Lippton H, and Kenigs VA. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 60: PL15-PL21, 1996.
21. Kjaer A, Knigge U, Rouleau A, Garbarg M, and Warberg J. Dehydration-induced release of vasopressin involves activation of hypothalamic histaminergic neurons. Endocrinology 135: 675-681, 1994.
22. Madeddu P, Salis MB, Milia AF, Emanueli C, Guerrini R, Regoli D, and Calo G. Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension 33: 914-919, 1999.
23. Marples D, Christensen BM, Frøkiær J, Knepper MA, and Nielsen S. Dehydration reverses vasopressin antagonist-induced diuresis and aquaporin-2 downregulation in rats. Am J Physiol Renal Physiol 275: F400-F409, 1998.
24. Marples D, Knepper MA, Christensen EI, and Nielsen S. Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol Cell Physiol 269: C655-C664, 1995.
25. 2 receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J Am Soc Nephrol 10: 2165-2170, 1999.
26. 1 receptor. Eur J Pharmacol 340: 1-15, 1997.
27. 1 receptor. Nature 377: 532-535, 1995.
28. 1) receptor. Peptides 21: 907-917, 2000.
29. Nielsen S, Frøkiær J, Marples D, Kwon TH, Agre P, and Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82: 205-244, 2002.
30. Nielsen S, Terris J, Andersen D, Ecelbarger C, Frøkiær J, Jonassen T, Marples D, Knepper MA, and Petersen JS. Congestive heart failure in rats is associated with increased expression and targeting of aquaporin-2 water channel in collecting duct. Proc Natl Acad Sci USA 94: 5450-5455, 1997.
31. Ohnishi A, Orita Y, Takagi N, Fujita T, Toyoki T, Ihara Y, Yamamura Y, Inoue T, and Tanaka T. Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in man. J Pharmacol Exp Ther 272: 546-551, 1995.
32. Petersen JS and Christensen S. Superiority of tetraethylammonium versus p-aminohippurate as a marker for renal plasma flow during furosemide diuresis. Ren Physiol 10: 102-109, 1987.
33. Petersen JS, Shalmi M, Lam HR, and Christensen S. Renal response of furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy. J Pharmacol Exp Ther 258: 1-7, 1991.
34. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, and Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270: 792-794, 1995.
35. Rizzi A, Rizzi D, Marzola G, Regoli D, Larsen BD, Petersen JS, and Calo' G. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice. Br J Pharmacol 137: 369-374, 2002.
36. 2 antagonist OPC 31260 in hydropenic humans. Kidney Int 48: 220-226, 1995.
37. Spannow J, Thomsen K, Petersen JS, Haugan K, and Christensen S. Influence of renal nerves and sodium balance on the acute antidiuretic effect of bendroflumethiazide in rats with diabetes insipidus. J Pharmacol Exp Ther 282: 1155-1162, 1997.
38. Staahltoft D, Nielsen S, Janjua NR, Christensen S, Skott O, Marcussen N, and Jonassen TE. Chronic losartan treatment normalizes renal water handling in rats with congestive heart failure. Am J Physiol Renal Physiol 282: F307-F315, 2002.
39. Thomsen K and Shirley DG. The validity of lithium clearance as an index of sodium and water delivery from the proximal tubules. Nephron 77: 125-138, 1997.
40. Van Balkom BW, Savelkoul PJ, Markovich D, Hofman E, Nielsen S, van der Sluijs P, and Deen PM. The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel. J Biol Chem 277:41473-41479, 2002.
41. Wong LL and Verbalis JG. Vasopressin V2 receptor antagonists. Cardiovasc Res 51: 391-402, 2001.
42. Xu DL, Martin PY, Ohara M, St John J, Pattison T, Meng X, Morris K, Kim JK, and Schrier RW. Upregulation of aquaporin-2 water channel expression in chronic heart failure in rat. J Clin Invest 99: 1500-1505, 1997.
43. Yasui M, Zelenin SM, Celsi G, and Aperia A. Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am J Physiol Renal Physiol 272: F443-F450, 1997.
44. 2 interaction with AVP: effects on AQP2 phosphorylation and distribution. Am J Physiol Renal Physiol 278: F388-F394, 2000.